InvestSMART

Orthocell Limited (ASX:OCC)

ALERT: Price-sensitive ASX Announcement for OCC
Current share price for OCC : $0.795 -0.005 (-0.63%)+
Announcement
Release
10 Mar 2026 9:08AM
Price at Release
$0.800
Full Release
download
Summary
Orthocell Limited has appointed LEDA Orthopaedics as the exclusive distributor for its Remplir™ product in the United Kingdom, part of a broader strategy to capitalize on a $750 million UK/EU peripheral nerve repair market. The company has submitted a regulatory application to the British Standards Institution, with approval expected in Q3 FY26, enabling a swift commercial launch. Orthocell's Australian teams will assist in the UK rollout, utilizing successful medical education approaches. The company has substantial cash reserves to support its global distribution strategy and ongoing market expansion.
Key Points
  • Orthocell has appointed LEDA Orthopaedics as the exclusive distributor for Remplir™ in the UK.
  • Orthocell submitted a regulatory application to the British Standards Institution for approval to distribute Remplir in the UK/EU market.
  • The UK/EU peripheral nerve repair market is valued at approximately $750 million.
  • Regulatory approval for Remplir in the UK is anticipated in the third quarter of fiscal year 2026.
  • LEDA Orthopaedics has extensive experience in orthopaedic technologies and maintains strong relationships with UK surgeons.
  • Early distributor appointments are made to prepare for rapid commercial launch post-approval.
  • Orthocell's Australian-based commercial teams will support the UK rollout, leveraging proven medical education programs.
  • Remplir is already approved and selling in several countries, including Australia, New Zealand, Singapore, the US, and Hong Kong.
  • Orthocell reported approximately $49 million in cash reserves as of 31 December 2025 to support its global distribution strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.